Correlation Between Eliem Therapeutics and Oncternal Therapeutics
Can any of the company-specific risk be diversified away by investing in both Eliem Therapeutics and Oncternal Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eliem Therapeutics and Oncternal Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eliem Therapeutics and Oncternal Therapeutics, you can compare the effects of market volatilities on Eliem Therapeutics and Oncternal Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eliem Therapeutics with a short position of Oncternal Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eliem Therapeutics and Oncternal Therapeutics.
Diversification Opportunities for Eliem Therapeutics and Oncternal Therapeutics
0.44 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Eliem and Oncternal is 0.44. Overlapping area represents the amount of risk that can be diversified away by holding Eliem Therapeutics and Oncternal Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Oncternal Therapeutics and Eliem Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eliem Therapeutics are associated (or correlated) with Oncternal Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Oncternal Therapeutics has no effect on the direction of Eliem Therapeutics i.e., Eliem Therapeutics and Oncternal Therapeutics go up and down completely randomly.
Pair Corralation between Eliem Therapeutics and Oncternal Therapeutics
Given the investment horizon of 90 days Eliem Therapeutics is expected to generate 0.57 times more return on investment than Oncternal Therapeutics. However, Eliem Therapeutics is 1.76 times less risky than Oncternal Therapeutics. It trades about -0.11 of its potential returns per unit of risk. Oncternal Therapeutics is currently generating about -0.15 per unit of risk. If you would invest 771.00 in Eliem Therapeutics on August 29, 2024 and sell it today you would lose (471.00) from holding Eliem Therapeutics or give up 61.09% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 98.4% |
| Values | Daily Returns |
Eliem Therapeutics vs. Oncternal Therapeutics
Performance |
| Timeline |
| Eliem Therapeutics |
| Oncternal Therapeutics |
Eliem Therapeutics and Oncternal Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Eliem Therapeutics and Oncternal Therapeutics
The main advantage of trading using opposite Eliem Therapeutics and Oncternal Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eliem Therapeutics position performs unexpectedly, Oncternal Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Oncternal Therapeutics will offset losses from the drop in Oncternal Therapeutics' long position.| Eliem Therapeutics vs. Pmv Pharmaceuticals | Eliem Therapeutics vs. MediciNova | Eliem Therapeutics vs. Pharvaris BV | Eliem Therapeutics vs. PepGen |
| Oncternal Therapeutics vs. CytomX Therapeutics | Oncternal Therapeutics vs. Assembly Biosciences | Oncternal Therapeutics vs. Instil Bio | Oncternal Therapeutics vs. Nuvation Bio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Other Complementary Tools
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |